Calendar
Sponsor Links
Partners

Philippines Travel Guide - Local Philippines
Site News

July 18,2012
Infrastructure Africa Business Forum recently concluded. It was a success! Congratulations to Siyenza Management!

May 31,2011
New feature in GoingtoMeet is the Conference Reminder


Click here for more news
Contact GoingtoMeet.com

Name
E-Mail
Message
for GTM
email alerts
media partnership
for event organizer (registration concerns only)

Fast Facts
 

Highlights

Personalised medicine, enabled by personalised ICT services, and providing genetic and genomic information of every individual, is designed to give each patient an individual therapeutically active drug while minimising the adverse effects.

Personalised medicine will only be successful when accurate diagnostic tests identify the patients who can benefit from targeted therapies and eventually reach the desired goal of prevention and prediction. The formidable challenges we are faced with in reaching this goal are numerous.

The scope of this conference is to connect high-level scientists across scientific domains, to support capacity building, and increase the impact of personalised medicine research on regulatory bodies, decision makers as well as the private sector.

The focus will be on the following:

  • Bring together researchers working on the latest scientific breakthrough developments of personalised medicine contributing to Europe’s research and innovation capacities;
  • Broaden the concept of personalised medicine from the genetically reductionist version to one that includes other types of markers;
  • Educate physicians and the public as a whole to these new developments. One of the major obstacles for making personalised medicine available for patients requires basic, translational, and also regulatory science, especially in the areas of ethical, legal and social issues;
  • To bridge science, policy makers and society in the area of Personalised Medicine.

Sessions will include:

  • Novelties in ICT for Personalised Medicine
  • Nanorobots and the Human Body
  • New Targets and inhibitors based on epigenetic
  • Natural products as a source for new drugs
  • Constellation thinking in the diagnosis and therapy
  • The evolving regulatory system and societal challenges
  • Empowering the Patient
  • Roundtables with stakeholders (Patients associations, General Practitioners Associations, Clinician Associations)

Confirmed speakers include:

  • Mary Baker - European Brain Council, UK
  • María Berdasco - Bellvitge Biomedical Research Institute (IDIBELL), ES
  • Stephane Berghmans - EMRC, FR
  • Maurizio Botta - University of Siena, IT
  • Jef De Brabander - UT Southwestern Medical Center, US
  • Anne Bruinvels - ELIXIOR, UK
  • Richard Frackowiak - University of Lausanne, CH
  • A. Ganesan - University of East Anglia, UK
  • Ursula Gundert-Remy - Federal Institute for Risk Assessment, DE
  • Manfred Jung - University of Freiburg, DE
  • Jonathan Knowles - EPLS, CH
  • Hans Lehrach - Max Planck Institute for Molecular Genetics, DE
  • Stavros Malas - Minister of Health, CY
  • Emmanuel Mikros - University of Athens, GR
  • Davor Milicic - University of Zagreb, HR
  • Christodoulos Nicolaou - Eli Lilly and Company, US
  • K.C. Nicolaou - The Scripps Research Institute, US
  • David Nutt - Imperial College London, UK
  • Barbara Prainsack - Brunel University London, UK
  • Kamran Sayrafian - NIST, US
  • Dina Simunic - University of Zagreb, HR
  • Albrecht von Müller - Parmenides Foundation, DE

A number of conference grants will be available for selected participants, in particular Early Stage Researchers.











Event Reminder

Registration Open
Call for Papers
Call for Speakers
Receive GTM eblast updates
Email
Security Code:

Contact Details

Contact person: Zuzana Vercinska
Event website: http://www.cost.eu/events/pemed
Phone: +32 2 533 38 05
Fax: +32 2 533 38 90

Contact Organizer

Contact Organizer